title: Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate.
abstract: An implant controlled-release system for protein drug delivery based on a polyion complex device composed of chitosan (CS) and sodium hyaluronate (HA) was investigated. The conditions which generated the greatest amount of the polyion solid complex were studied to ascertain the formation of polyion complex between CS and HA. The greatest amount of the polyion complex was formed at the weight ratio of 3 to 7 (CS:HA) at pH 3.5. Furthermore, the CS-HA pellets were prepared and then drug release from CS-HA pellets was evaluated using insulin as a model drug. The results demonstrated that the insulin release from CS-HA pellets was markedly influenced by both the change in the polymer mixing ratio and the total pellet weight, whereas the compression pressure did not affect the release significantly. An artificial neural network (ANN) and biharmonic spline interpolation (HSI) were employed to predict the actual relation between causal factors and the release rate constant of insulin. Although both the ANN and HSI successfully represented a non-linear relationship between the formulation factors and the release rate constant, HSI methodology gave a better estimation than that of the ANN.
authors.affiliation: Department of Pharmaceutics, Hoshi University, Ebara 2-4-41, Shinagawa, 142-8501 Tokyo, Japan.
authors.forename: Silvia
authors.initials: S
authors.lastname: Surini
authors.forename: Hidero
authors.initials: H
authors.lastname: Akiyama
authors.forename: Mariko
authors.initials: M
authors.lastname: Morishita
authors.forename: Tsuneji
authors.initials: T
authors.lastname: Nagai
authors.forename: Kozo
authors.initials: K
authors.lastname: Takayama
mesh_terms: D000276:Adjuvants, Immunologic / Q000737:chemistry*; D000277:Adjuvants, Pharmaceutic / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D002686:Chitin / Q000031:analogs & derivatives* / Q000737:chemistry*; D048271:Chitosan; D019245:Compressive Strength; D004339:Drug Compounding; D004343:Drug Implants; D006820:Hyaluronic Acid / Q000737:chemistry*; D007328:Insulin / Q000008:administration & dosage* / Q000737:chemistry
chemical_list: D000276:Adjuvants, Immunologic; D000277:Adjuvants, Pharmaceutic; D004343:Drug Implants; D007328:Insulin; D002686:Chitin; D006820:Hyaluronic Acid; D048271:Chitosan